Author Correction: A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion

Nat Rev Immunol. 2020 Oct;20(10):644. doi: 10.1038/s41577-020-00445-3.

Authors

Devin Dersh¹, Jaroslav Hollý¹, Jonathan W Yewdell²

Affiliations

¹ Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA.
² Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA. jyewdell@nih.gov.

PMID: 32873889
DOI: 10.1038/s41577-020-00445-3

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum